Total submissions: 26
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000044469 | SCV000072482 | benign | Hereditary breast ovarian cancer syndrome | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Counsyl | RCV000077334 | SCV000154088 | benign | Breast-ovarian cancer, familial, susceptibility to, 2 | 2014-03-18 | criteria provided, single submitter | literature only | |
Ambry Genetics | RCV000128957 | SCV000172838 | benign | Hereditary cancer-predisposing syndrome | 2014-11-19 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Eurofins Ntd Llc |
RCV000120328 | SCV000225182 | benign | not specified | 2014-08-04 | criteria provided, single submitter | clinical testing | |
Michigan Medical Genetics Laboratories, |
RCV000077334 | SCV000267769 | benign | Breast-ovarian cancer, familial, susceptibility to, 2 | 2016-04-21 | criteria provided, single submitter | clinical testing | |
A. |
RCV000414161 | SCV000492495 | uncertain significance | Breast neoplasm | criteria provided, single submitter | research | ||
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000044469 | SCV000494327 | benign | Hereditary breast ovarian cancer syndrome | 2014-03-28 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV000463461 | SCV000541066 | benign | Familial cancer of breast | 2017-02-23 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV001705697 | SCV000602797 | benign | not provided | 2023-11-29 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000128957 | SCV000683643 | likely benign | Hereditary cancer-predisposing syndrome | 2015-03-12 | criteria provided, single submitter | clinical testing | |
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000077334 | SCV000744460 | likely benign | Breast-ovarian cancer, familial, susceptibility to, 2 | 2015-09-21 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000120328 | SCV000805712 | benign | not specified | 2017-03-20 | criteria provided, single submitter | clinical testing | |
National Health Laboratory Service, |
RCV000044469 | SCV002026105 | benign | Hereditary breast ovarian cancer syndrome | 2022-04-19 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV000120328 | SCV002070581 | likely benign | not specified | 2021-12-08 | criteria provided, single submitter | clinical testing | |
Genetics Program, |
RCV000044469 | SCV002515113 | likely benign | Hereditary breast ovarian cancer syndrome | 2021-11-01 | criteria provided, single submitter | research | |
Sema4, |
RCV000128957 | SCV002533894 | benign | Hereditary cancer-predisposing syndrome | 2020-07-08 | criteria provided, single submitter | curation | |
CHEO Genetics Diagnostic Laboratory, |
RCV003149682 | SCV003838158 | likely benign | Breast and/or ovarian cancer | 2022-05-25 | criteria provided, single submitter | clinical testing | |
University of Washington Department of Laboratory Medicine, |
RCV000128957 | SCV003852014 | likely benign | Hereditary cancer-predisposing syndrome | 2023-03-23 | criteria provided, single submitter | curation | Missense variant in a coldspot region where missense variants are very unlikely to be pathogenic (PMID:31911673). |
ITMI | RCV000120328 | SCV000084480 | not provided | not specified | 2013-09-19 | no assertion provided | reference population | |
Sharing Clinical Reports Project |
RCV000077334 | SCV000109131 | benign | Breast-ovarian cancer, familial, susceptibility to, 2 | 2012-05-01 | no assertion criteria provided | clinical testing | |
Breast Cancer Information Core |
RCV000077334 | SCV000146468 | uncertain significance | Breast-ovarian cancer, familial, susceptibility to, 2 | 2002-05-29 | no assertion criteria provided | clinical testing | |
Department of Pathology and Laboratory Medicine, |
RCV000120328 | SCV001549977 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics Laboratory, |
RCV000120328 | SCV001906222 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV001705697 | SCV001931721 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV001705697 | SCV001951264 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Laboratory of Diagnostic Genome Analysis, |
RCV001705697 | SCV002035369 | likely benign | not provided | no assertion criteria provided | clinical testing |